Dr. Jeffrey Olin is a professor of medicine (cardiology) in the Mount Sinai School of Medicine, and serves the Mount Sinai Medical Center as director of vascular medicine in the Zena and Michael A. Wiener Cardiovascular Institute and the Marie-Josée and Henry R. Kravis Center for Cardiovascular Health.

Dr. Olin is an internationally recognized expert in the area of vascular medicine. He has held numerous leadership positions and has been at the forefront of establishing vascular medicine as a distinct subspecialty of Cardiovascular Medicine. He was instrumental in the formation of the American Board of Vascular Medicine, the first ever board examination in this specialty. He is a past president of the Society for Vascular Medicine and Biology and past member of the peripheral vascular disease committee of the American College of Cardiology. He is the immediate past chair of the interdisciplinary working group on atherosclerotic peripheral vascular disease and was instrumental in this working group becoming a new Council of the American Heart Association. He previously sat on the highest-ranking scientific committee of the American Heart Association, the Scientific Advisory and Coordinating Committee. He is a member of the Board of Directors of the American Board of Vascular Medicine and is one of four physicians selected to direct a credentialing task force for the credentialing of physicians in Vascular Ultrasound. 

Dr. Olin has been involved in clinical research involving peripheral arterial disease, renal artery disease, carotid artery disease, venous thromboembolic disease and has helped to develop new techniques to nonivasively diagnose renal artery stenosis and to nonsurgically treat patients who develop post catheterization pseudoaneurysms. Along with Dr. John Cooke, he is conducting the largest NIH study on the Genetics of Peripheral Arterial Disease. He is also the Mount Sinai Principle Investigator of the NIH sponsored CORAL trial studying the effect of stents in patients with atherosclerotic renal artery stenosis. In addition, Dr. Olin was the international Principle Investigator and Chair of the Steering Committee for a study of Immune Modulation Therapy for patients with Peripheral Arterial Disease. He is the current U.S. Principle Investigator for the WALK trial investigating the role of gene therapy to grow new blood vessels in patients with peripheral arterial disease and has been active in gene therapy trials to prevent amputation in those patients with circulatory problems of the legs.  

Dr. Olin has authored more than 175 scientific papers in the peer review literature, 3 books and more than 66 book chapters. He has served on many writing committees of the American College of Cardiology and American Heart Association. He is currently chairing the writing committee on Performance Measures in Peripheral Arterial Disease. He has published in the New England Journal of Medicine, Circulation, Journal of the American Medical Association, Journal of the American College of Cardiology, Journal of Vascular Surgery and Vascular Medicine just to name a few. He is an Associate Editor of the journal Vascular Medicine and editor of the textbook Peripheral Vascular Diseases.